Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07467434) titled 'FOLFIRINOX Induction Chemotherapy for Synchronous Liver Metastases' on March 8.

Study Type: Observational

Primary Sponsor: Assistance Publique - Hopitaux de Paris

Condition: Rectal Cancer Synchronous Liver Metastases Antineoplastic Combined Chemotherapy Protocols Surgical Therapy

Recruitment Status: Not recruiting

Date of First Enrollment: April 2026

Target Sample Size: 550

Countries of Recruitment: France

To know more, visit https://clinicaltrials.gov/study/NCT07467434

Published by HT Digital Content Services with permission from Health Daily Digest....